Based on the results of clinical trials conducted by Dr. Nobuya at the Kyushu Cancer Center in Japan.
The percentage of diseased cells that were “completely demolishing” or “shrink in size by more than half” in other organs after taking fucoidan is as follows:
| Organ | Percentage | Organ | Percentage |
| Tougue | 83% | Stomach | 84% |
| Pharynx | 81% | Pancreas | 48% |
| Esophagus | 84% | Colon | 80% |
| Breast | 78% | Blood | 84% |
| Uterus | 72% | Ovary | 58% |
| Sychronous Primary Lung | 86% | Prostate | 73% |
| Lung | 75% | Bladder | 72% |
| Lung (Small Cell) | 79% | ||
Company: SeaHerb Co., LTD.
CEO: Oh, Chungheon
Address: 276, Solchi-ro, Baebang-eup, Asan-si, Chungcheongnam-do, S.Korea
CS Center: mekabu@naver.com
Tel: +82 41-549-6466
Email: sh@seaherb.com
www.seaherb.com
